Buy Biocon, says Vishal Kshatriya, Sr Derivative and Technical Analyst of Edelweiss.
Kshatriya told CNBC-TV18, "I have a buy call on Biocon. Stock has generated trendline breakout along with good volumes placed on its daily charts. Besides this, stock has breached and closed above it 20 DMA, indicating positive momentum in the counter. Directional indicator ADS has given a buy signal. Trader can go long with target of Rs 350 and stoploss of Rs 335.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
